Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to ...

As of Friday, January 09, Collegium Pharmaceutical, Inc.’s COLL share price has dipped by 6.84%, which has investors questioning if this is right time to buy.

Book cover courtesy of Susan Coll. Susan Coll was already an established novelist when she started working at Politics and Prose in 2011, and she promised the store’s owners that she wouldn’t write ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...